HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A PMS2 non-canonical splicing site variant leads to aberrant splicing in a patient suspected for lynch syndrome.

Abstract
The PMS2 gene is one of the DNA mismatch repair genes (MMR) implicated in Lynch syndrome (LS). A subset of PMS2 pathogenic variants (PVs) are splice variants mostly affecting canonical GT/AG splicing sequences. However, the majority of the intronic variants outside canonical splice sites remained as variants of unknown significance, even though some of them would alter the splicing process. In this report, we describe the analysis of such an intronic variant (c.251-5T > C) detected in an 82-year-old patient diagnosed with endometrial cancer displaying microsatellite instability and the loss of PMS2 expression displayed. RNA analysis demonstrated that this variant lead to the complete exon 4 skipping, resulting in the synthesis of a truncated protein. This finding shows the relevance of functional RNA analysis in the non-canonical intronic variant assessment and the importance of systematic evaluation of MSI/loss of expression of MMR genes for LS screening in patients with endometrial cancers.
AuthorsAhmed Bouras, Pierre Naibo, Clémentine Legrand, François Le Marc'hadour, Eric Ruano, Chloé Grand-Masson, Cedrick Lefol, Qing Wang
JournalFamilial cancer (Fam Cancer) Vol. 22 Issue 3 Pg. 303-306 (Jul 2023) ISSN: 1573-7292 [Electronic] Netherlands
PMID36445599 (Publication Type: Case Reports, Journal Article)
Copyright© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Chemical References
  • Mismatch Repair Endonuclease PMS2
  • MutL Protein Homolog 1
  • PMS2 protein, human
Topics
  • Humans
  • Aged, 80 and over
  • Colorectal Neoplasms, Hereditary Nonpolyposis (diagnosis)
  • Mismatch Repair Endonuclease PMS2 (genetics, metabolism)
  • Germ-Line Mutation
  • Mutation
  • DNA Mismatch Repair (genetics)
  • Microsatellite Instability
  • MutL Protein Homolog 1 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: